WO2013013240A3 - Macrocyclic compounds and related compositons and methods of use - Google Patents
Macrocyclic compounds and related compositons and methods of use Download PDFInfo
- Publication number
- WO2013013240A3 WO2013013240A3 PCT/US2012/047863 US2012047863W WO2013013240A3 WO 2013013240 A3 WO2013013240 A3 WO 2013013240A3 US 2012047863 W US2012047863 W US 2012047863W WO 2013013240 A3 WO2013013240 A3 WO 2013013240A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositons
- methods
- macrocyclic compounds
- compounds
- macrocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compounds and compositions, which can be use for example, for treating cancer, are described herein.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510177P | 2011-07-21 | 2011-07-21 | |
| US61/510,177 | 2011-07-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2013013240A2 WO2013013240A2 (en) | 2013-01-24 |
| WO2013013240A3 true WO2013013240A3 (en) | 2013-07-11 |
Family
ID=47558755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2012/047863 Ceased WO2013013240A2 (en) | 2011-07-21 | 2012-07-23 | Macrocyclic compounds and related compositons and methods of use |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2013013240A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3110877A1 (en) * | 2018-08-27 | 2020-03-05 | Spinogenix, Inc. | Fascin binding compounds for spinogenesis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070037852A1 (en) * | 2003-03-28 | 2007-02-15 | Danishefsky Samuel J | Migrastatin analogs and uses thereof |
| US20090124662A1 (en) * | 2004-05-25 | 2009-05-14 | Danishefsky Samuel J | Migrastatin analogs in the treatment of cancer |
-
2012
- 2012-07-23 WO PCT/US2012/047863 patent/WO2013013240A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070037852A1 (en) * | 2003-03-28 | 2007-02-15 | Danishefsky Samuel J | Migrastatin analogs and uses thereof |
| US20090124662A1 (en) * | 2004-05-25 | 2009-05-14 | Danishefsky Samuel J | Migrastatin analogs in the treatment of cancer |
Non-Patent Citations (1)
| Title |
|---|
| ANQUETIN G. ET AL.: "Synthesis of Novel Migrastatin and Dorrigocin A Analogu es from D-Glucal", CHEMISTRY A EUROPEAN JOURNAL, vol. 14, no. 5, 2008, pages 1592 - 1600 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013013240A2 (en) | 2013-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2523944A4 (en) | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating | |
| WO2014052836A3 (en) | Methods and compositions for treating infection | |
| EP2721033A4 (en) | Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers | |
| WO2013056148A3 (en) | Scd1 antagonists for treating cancer | |
| HK1199100A1 (en) | Methods and compositions for the treatment and diagnosis of colorectal cancer | |
| WO2012054862A9 (en) | Agents, compositions, and methods for treating pruritis and related skin conditions | |
| WO2013119916A3 (en) | Compounds for treating spinal muscular atrophy | |
| WO2012149472A9 (en) | Methods, compositions, and kits for treating and preventing neurological conditions | |
| HK1198689A1 (en) | Antibody formulations and methods | |
| AU2013216320A8 (en) | C10RF32 Antibodies, And Uses Thereof For Treatment Of Cancer | |
| WO2013120022A3 (en) | Treatment of hypoglycemia | |
| HK1202313A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
| MY177344A (en) | Compounds and their methods of use | |
| MX2014012477A (en) | Pyrrolopyrazone inhibitors of tankyrase. | |
| WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
| PH12013500529A1 (en) | Methods and compositions for treating lung cancer | |
| WO2011129936A3 (en) | Compositions and methods for the prevention and treatment of cancer | |
| EP2996721A4 (en) | Methods and compositions for prognosis, diagnosis and treatment of adam8-expressing cancer | |
| WO2012017321A3 (en) | Treatment for dyslipidemia | |
| WO2013052108A3 (en) | Methods and compositions for the treatment and diagnosis of ovarian cancer | |
| WO2012170742A3 (en) | Treatment and prevention of cancer with hmgb1 antagonists | |
| WO2012170720A3 (en) | Methods and compositions for treating brain cancer | |
| EP3089745A4 (en) | Compounds, compositions, and methods for the treatment of cancers | |
| WO2012106702A3 (en) | Treatment of leukemia | |
| WO2012024670A3 (en) | Composition and methods for treating glioblastoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12815296 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12815296 Country of ref document: EP Kind code of ref document: A2 |